This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Simon Eastman: Innovator in Liposomal Formulations
Introduction
Simon Eastman is a notable inventor based in Delta, California. He has made significant contributions to the field of biochemistry, particularly in the development of liposomal formulations. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
Simon Eastman holds a patent for a "Liposomal formulation of nonglycosidic ceramides and uses thereof." This invention provides liposomes containing nonglycosidic ceramides within their bilayers, along with compositions thereof. These liposomes are designed to activate murine iNKT cells and induce dendritic cell (DC) maturation, both in vitro and in vivo, at an efficacy comparable to their corresponding soluble nonglycosidic ceramides. Additionally, the patent outlines methods for treating diseases using these liposomes and compositions.
Career Highlights
Eastman is associated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research and innovations. His work is pivotal in exploring new therapeutic avenues in cancer treatment.
Collaborations
Simon Eastman collaborates with Vincenzo Cerundolo, a fellow researcher in the field. Their partnership enhances the potential for groundbreaking discoveries in their area of expertise.
Conclusion
Simon Eastman's contributions to liposomal formulations represent a significant advancement in medical research. His innovative approach and dedication to improving treatment methods highlight the importance of continued research in this field.